[1]
Kesen, O. et al. 2019. Evaluation of depression, anxiety and quality of life in hepatitis C patients who treated with direct acting antiviral agents. Turkish Journal of Gastroenterology. 30, 9 (Jan. 2019), 801–806. DOI:https://doi.org/10.5152/tjg.2019.18679.